Literature DB >> 24955779

Poly(styrene-alt-maleic anhydride)-based diblock copolymer micelles exhibit versatile hydrophobic drug loading, drug-dependent release, and internalization by multidrug resistant ovarian cancer cells.

Michael P Baranello1, Louisa Bauer, Danielle S W Benoit.   

Abstract

Amphiphilic diblock copolymers of poly(styrene-alt-maleic anhydride)-b-poly(styrene) (PSMA-b-PS) and poly(styrene-alt-maleic anhydride)-b-poly(butyl acrylate) (PSMA-b-PBA) were synthesized via reversible addition-fragmentation chain transfer (RAFT) polymerizations. Polymers were well-controlled with respect to molecular weight evolution and polydispersity indices (PDI < 1.2). Additionally, RAFT allowed for control of diblock compositions (i.e., ratio of hydrophilic PSMA blocks to hydrophobic PS/PBA blocks) and overall molecular weight, which resulted in reproducible self-assembly of diblocks into micelle nanoparticles with diameters of 20-100 nm. Parthenolide (PTL), a hydrophobic anticancer drug, was loaded and released from the micelles. The highest loading and prolonged release of PTL was observed from predominantly hydrophobic PSMA-b-PS micelles (e.g., PSMA100-b-PS258), which exhibited the most ordered hydrophobic environment for more favorable core-drug interactions. PSMA100-b-PS258 micelles were further loaded with doxorubicin (DOX), as well as two hydrophobic fluorescent probes, nile red and IR-780. While PTL released quantitatively within 24 h, DOX, IR-780, and nile red showed release over 1 week, suggesting stronger drug-core interactions and/or hindrance due to less favorable drug-solvent interactions. Finally, uptake and intracellular localization of PSMA100-b-PS258 micelles by multidrug resistant (MDR) ovarian cancer cells was observed by transmission electron microscopy (TEM). Additionally, in vitro analyses showed DOX-loaded PSMA-b-PS micelles exhibited greater cytotoxicity to NCI/ADR RES cells than equivalent free DOX doses (75% reduction in cell viability by DOX-loaded micelles compared to 40% reduction in viability by free DOX at 10 μM DOX), likely due to avoidance of MDR mechanisms that limit free hydrophobic drug accumulation. The ability of micelles to achieve intracellular delivery via avoidance of MDR mechanisms, along with the versatility of chemical constituents and drug loading and release rates, offer many advantages for a variety of drug delivery applications.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24955779     DOI: 10.1021/bm500468d

Source DB:  PubMed          Journal:  Biomacromolecules        ISSN: 1525-7797            Impact factor:   6.988


  16 in total

1.  Ligand Density Controls C-Type Lectin-Like Molecule-1 Receptor-Specific Uptake of Polymer Nanoparticles.

Authors:  Marian A Ackun-Farmmer; Kharimat L Alatise; Griffin Cross; Danielle S W Benoit
Journal:  Adv Biosyst       Date:  2020-10-19

2.  pH-activated nanoparticles for controlled topical delivery of farnesol to disrupt oral biofilm virulence.

Authors:  Benjamin Horev; Marlise I Klein; Geelsu Hwang; Yong Li; Dongyeop Kim; Hyun Koo; Danielle S W Benoit
Journal:  ACS Nano       Date:  2015-02-13       Impact factor: 15.881

3.  Multivalent Presentation of Peptide Targeting Groups Alters Polymer Biodistribution to Target Tissues.

Authors:  Maureen R Newman; Steven G Russell; Christopher S Schmitt; Ian A Marozas; Tzong-Jen Sheu; J Edward Puzas; Danielle S W Benoit
Journal:  Biomacromolecules       Date:  2017-12-28       Impact factor: 6.988

4.  Retroductal Nanoparticle Injection to the Murine Submandibular Gland.

Authors:  Jomy J Varghese; Isaac L Schmale; Yuchen Wang; Mollie Eva Hansen; Shawn D Newlands; Catherine E Ovitt; Danielle S W Benoit
Journal:  J Vis Exp       Date:  2018-05-03       Impact factor: 1.355

5.  Enhanced design and formulation of nanoparticles for anti-biofilm drug delivery.

Authors:  Kenneth R Sims; Yuan Liu; Geelsu Hwang; Hoi In Jung; Hyun Koo; Danielle S W Benoit
Journal:  Nanoscale       Date:  2018-12-20       Impact factor: 7.790

6.  Nanoparticle-Mediated Delivery of Micheliolide Analogs to Eliminate Leukemic Stem Cells in the Bone Marrow.

Authors:  Marian A Ackun-Farmmer; Hanan Alwaseem; Michele Counts; Andrew Bortz; Simone Giovani; Benjamin J Frisch; Rudi Fasan; Danielle S W Benoit
Journal:  Adv Ther (Weinh)       Date:  2021-10-08

7.  Micelle Delivery of Parthenolide to Acute Myeloid Leukemia Cells.

Authors:  Michael P Baranello; Louisa Bauer; Craig T Jordan; Danielle S W Benoit
Journal:  Cell Mol Bioeng       Date:  2015-04-25       Impact factor: 2.321

8.  Characterization and optimization of pH-responsive polymer nanoparticles for drug delivery to oral biofilms.

Authors:  Jiayi Zhou; Benjamin Horev; Geelsu Hwang; Marlise I Klein; Hyun Koo; Danielle S W Benoit
Journal:  J Mater Chem B       Date:  2015-11-20       Impact factor: 6.331

9.  Fracture-Targeted Delivery of β-Catenin Agonists via Peptide-Functionalized Nanoparticles Augments Fracture Healing.

Authors:  Yuchen Wang; Maureen R Newman; Marian Ackun-Farmmer; Michael P Baranello; Tzong-Jen Sheu; J Edward Puzas; Danielle S W Benoit
Journal:  ACS Nano       Date:  2017-09-13       Impact factor: 15.881

Review 10.  Development of controlled drug delivery systems for bone fracture-targeted therapeutic delivery: A review.

Authors:  Yuchen Wang; Maureen R Newman; Danielle S W Benoit
Journal:  Eur J Pharm Biopharm       Date:  2018-02-19       Impact factor: 5.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.